Karuna Therapeutics (Acquired)
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. The company focuses on research and development in areas such as oncology, hematology, immunology, and cardiovascular diseases, with a mission to transform patients' lives through science.
Industries
Nr. of Employees
large (251-1000)
Karuna Therapeutics (Acquired)
Bristol Myers Squibb Belgium, Brussels, Belgium
Patents
Compositions and methods for treating disorders ameliorated by muscarinic receptor activation
US-11890378-B2
View DetailsCompositions and methods for treating disorders ameliorated by muscarinic receptor activation
US-11471413-B2
View DetailsCompositions and methods for treating disorders ameliorated by muscarinic receptor activation
US-11452692-B2
View DetailsCompositions and methods for treating disorders ameliorated by muscarinic receptor activation
US-10933020-B2
View DetailsCompositions and methods for treatment of disorders ameliorated by muscarinic receptor activation
US-10925832-B2
View Details
Compositions and methods for treating disorders ameliorated by muscarinic receptor activation
US-11890378-B2
View DetailsCompositions and methods for treating disorders ameliorated by muscarinic receptor activation
US-11471413-B2
View DetailsCompositions and methods for treating disorders ameliorated by muscarinic receptor activation
US-11452692-B2
View DetailsCompositions and methods for treating disorders ameliorated by muscarinic receptor activation
US-10933020-B2
View DetailsCompositions and methods for treatment of disorders ameliorated by muscarinic receptor activation
US-10925832-B2
View DetailsProducts
Radiopharmaceutical manufacturing hub
A dedicated manufacturing and supply hub for next‑generation radiopharmaceutical therapies, supporting production and global distribution.
Global R&D hub network (translational research centers)
Distributed R&D centers providing translational research, platform development and cross-site collaboration to accelerate discovery.
Healthcare professional digital portals and patient apps
Digital platforms providing educational materials, clinical guidance and disease‑specific resources for HCPs and patients.
Radiopharmaceutical manufacturing hub
A dedicated manufacturing and supply hub for next‑generation radiopharmaceutical therapies, supporting production and global distribution.
Global R&D hub network (translational research centers)
Distributed R&D centers providing translational research, platform development and cross-site collaboration to accelerate discovery.
Healthcare professional digital portals and patient apps
Digital platforms providing educational materials, clinical guidance and disease‑specific resources for HCPs and patients.
Services
Online registry and matching service to help researchers list trials and identify eligible participants.
Provision of product information, clinical resources and dedicated contact channels for healthcare professionals.
Regional pharmacovigilance operations and adverse event reporting infrastructure.
Administration of external grant programs and scholarships supporting scientific education and training.
Resources and programs to help patients understand coverage and access financial support for medicines.
Online registry and matching service to help researchers list trials and identify eligible participants.
Provision of product information, clinical resources and dedicated contact channels for healthcare professionals.
Regional pharmacovigilance operations and adverse event reporting infrastructure.
Administration of external grant programs and scholarships supporting scientific education and training.
Resources and programs to help patients understand coverage and access financial support for medicines.
Expertise Areas
- Clinical trial management
- Cell and gene therapy development
- Oncology and immuno-oncology R&D
- Radiopharmaceutical development and manufacturing
Key Technologies
- Cell therapy (CAR‑T)
- Radiopharmaceutical therapy production
- Biomarker discovery
- Whole‑genome sequencing
News & Updates
Bristol Myers Squibb announced its financial results for the second quarter of 2025.
RayzeBio’s new facility in Indianapolis is advancing cancer treatment with next-generation radiopharmaceutical therapies.
A global cycling event involving 300+ employees from 33 nations to support cancer research.
Bristol Myers Squibb announced its financial results for the second quarter of 2025.
RayzeBio’s new facility in Indianapolis is advancing cancer treatment with next-generation radiopharmaceutical therapies.
A global cycling event involving 300+ employees from 33 nations to support cancer research.